<DOC>
	<DOCNO>NCT01524276</DOCNO>
	<brief_summary>The purpose Registry provide continue evaluation periodic reporting safety effectiveness Medtronic market-released product . The Registry data intend benefit support interest patient , hospital , clinician , regulatory body , payer , industry streamline clinical surveillance process facilitate lead edge performance assessment via least burdensome approach .</brief_summary>
	<brief_title>Product Surveillance Registry</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Nervous System Diseases</mesh_term>
	<mesh_term>Digestive System Diseases</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Arrhythmias , Cardiac</mesh_term>
	<criteria>Patient legally authorize representative provide write authorization and/or consent per institution geographical requirement Patient intend receive treat eligible Medtronic product Patient within enrollment window relative therapy initiation meet criteria retrospective enrollment Patient , , inaccessible followup Patient exclusion criterion require local law Patient currently enrol plan enroll concurrent drug and/or device study may confound result</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>